saringosterol and Atherosclerosis

saringosterol has been researched along with Atherosclerosis* in 1 studies

Other Studies

1 other study(ies) available for saringosterol and Atherosclerosis

ArticleYear
Saringosterol from
    Marine drugs, 2021, Aug-26, Volume: 19, Issue:9

    Dysregulation of cholesterol homeostasis is a major risk factor of atherosclerosis, which can lead to serious health problems, including heart attack and stroke. Liver X receptor (LXR) α and β are transcription factors belonging to the nuclear receptor superfamily, which play important roles in cholesterol homeostasis. Selectively activating LXRβ provides a promising strategy for the treatment of atherosclerosis. Here, we employed atherosclerotic apoE-knockout mice to evaluate the effects of saringosterol, a phytosterol with potent and selective action for LXRβ, which we identified previously in edible marine seaweed

    Topics: Animals; Atherosclerosis; Cholesterol; Cytochrome P-450 Enzyme System; Diet, High-Fat; Hypolipidemic Agents; Intestinal Mucosa; Lipid Metabolism; Liver; Macrophages; Membrane Transport Proteins; Mice, Knockout, ApoE; Sargassum; Stigmasterol

2021